Table 1.
Demographic and Clinical Characteristics of Study Participants
| Variables | APTB-no T2DM Group (n = 790) | APTB-T2DM Group (n = 201) | P value |
|---|---|---|---|
| Gender | |||
| Male (%) | 504 (63.8) | 103 (51.2) | <0.001 |
| Age (mean±SE) | 44.05 ± 0.74 | 53.62 ± 1.04 | <0.001 |
| Fasting blood sugar | 4.89 ± 0.02 | 8.31 ± 0.23 | <0.001 |
| Laboratory parameters (mean ± SE) | |||
| Neutrophil (*10^9/L) | 4.01 ± 0.07 | 5.37 ± 0.20 | <0.001 |
| Lymphocyte (*10^9/L) | 1.55 ± 0.02 | 1.38 ± 0.05 | 0.001 |
| Monocyte (*10^9/L) | 0.44 ± 0.01 | 0.48 ± 0.02 | 0.014 |
| Albumin (g/L) | 38.92 ± 0.20 | 36.52 ± 0.44 | <0.001 |
| HDL (mmol/L) | 1.29 ± 0.02 | 1.10 ± 0.04 | <0.001 |
| CRP (mg/L) | 23.54 ± 1.52 | 42.19 ± 3.67 | <0.001 |
| Inflammatory parameters (mean ± SE) | |||
| MHR | 0.43 ± 0.01 | 0.54 ± 0.03 | <0.001 |
| NHR | 3.85 ± 0.10 | 5.75 ± 0.30 | <0.001 |
| CAR | 0.71 ± 0.05 | 1.32 ± 0.13 | <0.001 |
| CLR | 23.43 ± 2.02 | 56.21 ± 7.40 | <0.001 |
Abbreviations: HDL, high-density lipoprotein; CRP, C-reactive protein; MHR, monocyte to high-density lipoprotein ratio; NHR, neutrophil to high-density lipoprotein ratio; CAR, C-reactive protein to albumin ratio; CLR, C-reactive protein to lymphocyte ratio.